AU746174B2 - VLA-4 antagonists - Google Patents
VLA-4 antagonists Download PDFInfo
- Publication number
- AU746174B2 AU746174B2 AU28292/99A AU2829299A AU746174B2 AU 746174 B2 AU746174 B2 AU 746174B2 AU 28292/99 A AU28292/99 A AU 28292/99A AU 2829299 A AU2829299 A AU 2829299A AU 746174 B2 AU746174 B2 AU 746174B2
- Authority
- AU
- Australia
- Prior art keywords
- alkyl
- substituted
- aryl
- alkenyl
- mono
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/42—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1233698A | 1998-01-23 | 1998-01-23 | |
| US09/012336 | 1998-01-23 | ||
| US11072398P | 1998-12-03 | 1998-12-03 | |
| US60/110723 | 1998-12-03 | ||
| PCT/EP1999/000384 WO1999037605A1 (en) | 1998-01-23 | 1999-01-21 | Vla-4 antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2829299A AU2829299A (en) | 1999-08-09 |
| AU746174B2 true AU746174B2 (en) | 2002-04-18 |
Family
ID=26683440
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU28292/99A Ceased AU746174B2 (en) | 1998-01-23 | 1999-01-21 | VLA-4 antagonists |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1049665A1 (enExample) |
| JP (1) | JP4564654B2 (enExample) |
| KR (1) | KR20010034317A (enExample) |
| CN (1) | CN1294576A (enExample) |
| AU (1) | AU746174B2 (enExample) |
| BR (1) | BR9907733A (enExample) |
| CA (1) | CA2318639A1 (enExample) |
| EE (1) | EE200000428A (enExample) |
| HU (1) | HUP0100336A3 (enExample) |
| ID (1) | ID26665A (enExample) |
| IL (1) | IL137329A0 (enExample) |
| NO (1) | NO20003694L (enExample) |
| WO (1) | WO1999037605A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HK1045157A1 (zh) | 1999-01-22 | 2002-11-15 | 依兰制药公司 | 抑制vla-4介导的白细胞粘着的化合物 |
| WO2000043369A1 (en) * | 1999-01-22 | 2000-07-27 | Elan Pharmaceuticals, Inc. | Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| US6436904B1 (en) | 1999-01-25 | 2002-08-20 | Elan Pharmaceuticals, Inc. | Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| AU3246600A (en) | 1999-03-01 | 2000-09-21 | Elan Pharmaceuticals, Inc. | Alpha-aminoacetic acid derivatives useful as alpha 4 beta 7 receptor antagonists |
| CA2388686A1 (en) * | 1999-12-07 | 2001-06-14 | Sompong Wattanasin | Vla-4 integrin antagonists |
| YU41202A (sh) * | 1999-12-28 | 2005-03-15 | Pfizer Products Inc. | Ne-peptidni inhibitori vezivanja za ćeliju zavisnog od vla-4 korisni pri tretiranju inflamatornih, autoimunih i respiratornih bolesti |
| DE10019755A1 (de) * | 2000-04-20 | 2001-11-08 | Bayer Ag | Neue Aminoaryl/cycloalkylcarbonsäuren als Integrinantagonisten |
| GB2369357A (en) * | 2000-10-09 | 2002-05-29 | Bayer Ag | Aliphatic, cyclic amino carboxylic acids as integrin antagonists |
| GB2367816A (en) | 2000-10-09 | 2002-04-17 | Bayer Ag | Urea- and thiourea-containing derivatives of beta-amino acids |
| GB2377933A (en) | 2001-07-06 | 2003-01-29 | Bayer Ag | Succinic acid derivatives useful as integrin antagonists |
| TWI281470B (en) | 2002-05-24 | 2007-05-21 | Elan Pharm Inc | Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins |
| TW200307671A (en) | 2002-05-24 | 2003-12-16 | Elan Pharm Inc | Heteroaryl compounds which inhibit leukocyte adhesion mediated by α 4 integrins |
| TW200610754A (en) * | 2004-06-14 | 2006-04-01 | Daiichi Seiyaku Co | Vla-4 inhibitor |
| GB0523576D0 (en) * | 2005-11-18 | 2005-12-28 | Theradeas Ltd | Drug composition and its use in therapy |
| EA017110B1 (ru) | 2006-02-27 | 2012-09-28 | Элан Фамэсьютикэлс, Инк. | ПИРИМИДИНИЛСУЛЬФОНАМИДНЫЕ СОЕДИНЕНИЯ (ВАРИАНТЫ), СПОСОБ ПОЛУЧЕНИЯ ПИРИМИДИНИЛСУЛЬФОНАМИДНЫХ СОЕДИНЕНИЙ (ВАРИАНТЫ), ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, СПОСОБ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЯ, ОПОСРЕДОВАННОГО ИНТЕГРИНОМ α4, СПОСОБ СНИЖЕНИЯ И/ИЛИ ПРЕДУПРЕЖДЕНИЯ ВОСПАЛИТЕЛЬНОГО КОМПОНЕНТА ЗАБОЛЕВАНИЯ ИЛИ АУТОИММУННОГО ОТВЕТА |
| AU2008219007A1 (en) | 2007-02-20 | 2008-08-28 | Merrimack Pharmaceuticals, Inc. | Methods of treating multiple sclerosis by administration of alpha-fetoprotein in combination with an integrin antagonist |
| JP5639039B2 (ja) | 2008-04-11 | 2014-12-10 | メリマック ファーマシューティカルズ インコーポレーティッド | ヒト血清アルブミンリンカーおよびそのコンジュゲート |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6306840B1 (en) * | 1995-01-23 | 2001-10-23 | Biogen, Inc. | Cell adhesion inhibitors |
| SK9372000A3 (en) * | 1997-12-23 | 2002-03-05 | Rhone Poulenc Rorer Ltd | Substituted beta-alanines |
-
1999
- 1999-01-21 CN CN99803780A patent/CN1294576A/zh active Pending
- 1999-01-21 KR KR1020007008039A patent/KR20010034317A/ko not_active Withdrawn
- 1999-01-21 BR BR9907733-7A patent/BR9907733A/pt not_active IP Right Cessation
- 1999-01-21 EP EP99908811A patent/EP1049665A1/en not_active Withdrawn
- 1999-01-21 AU AU28292/99A patent/AU746174B2/en not_active Ceased
- 1999-01-21 JP JP2000528529A patent/JP4564654B2/ja not_active Expired - Fee Related
- 1999-01-21 ID IDW20001404A patent/ID26665A/id unknown
- 1999-01-21 WO PCT/EP1999/000384 patent/WO1999037605A1/en not_active Ceased
- 1999-01-21 EE EEP200000428A patent/EE200000428A/xx unknown
- 1999-01-21 HU HU0100336A patent/HUP0100336A3/hu unknown
- 1999-01-21 IL IL13732999A patent/IL137329A0/xx unknown
- 1999-01-21 CA CA002318639A patent/CA2318639A1/en not_active Abandoned
-
2000
- 2000-07-19 NO NO20003694A patent/NO20003694L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20003694D0 (no) | 2000-07-19 |
| WO1999037605A1 (en) | 1999-07-29 |
| CN1294576A (zh) | 2001-05-09 |
| HUP0100336A2 (hu) | 2001-07-30 |
| ID26665A (id) | 2001-01-25 |
| EE200000428A (et) | 2001-12-17 |
| KR20010034317A (ko) | 2001-04-25 |
| IL137329A0 (en) | 2001-07-24 |
| BR9907733A (pt) | 2000-10-17 |
| JP2002501039A (ja) | 2002-01-15 |
| NO20003694L (no) | 2000-09-20 |
| HUP0100336A3 (en) | 2002-11-28 |
| JP4564654B2 (ja) | 2010-10-20 |
| EP1049665A1 (en) | 2000-11-08 |
| AU2829299A (en) | 1999-08-09 |
| CA2318639A1 (en) | 1999-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2725690B2 (ja) | カルボキシアルキルペプチド誘導体 | |
| WO2001068586A2 (en) | α4β1 AND α4β7 INTEGRIN INHIBITORS | |
| AU2829299A (en) | Vla-4 antagonists | |
| US6365619B1 (en) | Treatment of arteriosclerosis | |
| EP0805796B1 (en) | Cell adhesion inhibitors | |
| BG65755B1 (bg) | Инхибитори на клетъчна адхезия | |
| HUP0104867A2 (hu) | Gyulladásos betegségek kezelésére használható heterociklusos vegyületek, eljárás előállításukra és ilyen vegyületeket tartalmazó gyógyászati készítmények és alkalmazásuk | |
| JP2002501039A5 (enExample) | ||
| US7196112B2 (en) | Cell adhesion inhibitors | |
| US6407065B1 (en) | VLA-4 antagonists | |
| MXPA01007187A (es) | Derivados de 2, 3-o-isopropilideno de monosacaridos como inhibidores de adhesion celular. | |
| JPS6230762A (ja) | 新規５−オキソ−１−イミダゾリジンアセトアミド誘導体 | |
| MXPA00007186A (en) | Vla-4 antagonists | |
| ES2278928T3 (es) | Inhibidores de triptasa. | |
| CZ20002704A3 (cs) | Antagonisté VLA-4 a farmaceutický prostředek, který je obsahuje | |
| US20020091142A1 (en) | Alpha4beta1 and alpha4beta7 integrin inhibitors | |
| US20260138964A1 (en) | Preparation of phenethylamines and cathinones and stereoisomers thereof and precursors thereof | |
| AU3006401A (en) | Vla-4 integrin antagonists | |
| AU766538B2 (en) | Cell adhesion inhibitors | |
| JPH024767A (ja) | 薬理作用を有するペプチド類 | |
| JPH01110695A (ja) | アミノ酸誘導体その製造方法及び血圧降下剤 | |
| HK1005241B (en) | Cell adhesion inhibitors | |
| HK1099708A (en) | Cell adhesion inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |